Galectin-3 as a Risk Factor for Adverse Cardiovascular Events in Long-Term Monitoring of Patients with Right Ventricular Myocardial Infarction on the Background of the Q-Myocardial Infarction of the Left Ventricular Posterior Wall

Authors

  • V.Y. Tseluiko Kharkiv Medical Academy of Postgraduate Education, Kharkiv
  • T.A. Lozova Sumy City Clinical Hospital № 1, Sumy
  • O.S. Sasiuk Sumy City Clinical Hospital № 1, Sumy

DOI:

https://doi.org/10.22141/2224-0586.6.69.2015.78659

Keywords:

galectin-3, right ventricular myocardial infarction, cardiovascular complications, predictors

Abstract

There has been studied the prognostic value of galectin-3 in the development of cardiovascular complications at 30-month follow-up of the 155 patients with right ventricular myocardial infarction on the background of the Q-myocardial infarction of the left ventricular posterior wall. The level of galectin-3 was determined on the 2nd day of acute infarction and after 6 months of follow-up (Platinun ELISA). A prognostic significance of galectin-3 in the development of unstable angina, myocardial re-infarctions, acute cerebrovascular accidents and cardiovascular death within 30 months has been proved. The connection was established between the high concentration of galectin-3 6 months after right ventricular myocardial infarction and the incidence of the combined cardiovascular endpoint.

Downloads

Download data is not yet available.

Published

2015-10-21

How to Cite

Tseluiko, V., Lozova, T., & Sasiuk, O. (2015). Galectin-3 as a Risk Factor for Adverse Cardiovascular Events in Long-Term Monitoring of Patients with Right Ventricular Myocardial Infarction on the Background of the Q-Myocardial Infarction of the Left Ventricular Posterior Wall. EMERGENCY MEDICINE, (6.69), 61–65. https://doi.org/10.22141/2224-0586.6.69.2015.78659

Issue

Section

Original Researches